Provention Bio, Inc. Profile Avatar - Palmy Investing

Provention Bio, Inc.

Provention Bio, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases. Its products candidates include PRV-031 teplizumab and mon…

Biotechnology
US, Red Bank [HQ]

Government Awards Analysis Beta

Obligations Over-Time

Awards
Obligations

Provention Bio, Inc. has no obligation with a government/award agency.

Latest Obligations

Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. Previous FY
Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0

Spending By Type

Awards
Obligations

Provention Bio, Inc. can't present spending by time.

Get PRO Today

With PRO you will unlock all insights related to government awards of Provention Bio, Inc..

End of PRVB's Analysis
CIK: 1695357 CUSIP: 74374N102 ISIN: US74374N1028 LEI: - UEI: -
Secondary Listings
PRVB has no secondary listings inside our databases.